Iron is essential to all microorganisms. To obtain iron from the very low concentrations present in their environment, microorganisms have developed sophisticated mechanisms such as the siderophore system. As a primitive defense mechanism, humans have developed mechanisms to withhold iron from microorganisms. Iron-binding proteins such as transferrin, ferritin, and lactoferrin have a central role in human ferrokinetics. These iron-binding proteins also participate in the process of decreasing iron availability for the microorganisms. They do so by decreasing iron reutilization. Anemia of inflammation (previously called anemia of chronic disease) is seen in the setting of infectious, inflammatory, and neoplastic diseases. It results, in part, from changes in the intracellular metabolism of iron. Alterations of iron physiology seen in many clinical circumstances make excess iron available to microorganisms, thus enhancing their pathogenicity. Understanding the molecular basis of iron withholding by the human host, both in the absence of and during infection, and that of iron acquisition by microorganisms may provide us with new and innovative antimicrobial agents and vaccines.
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Iron is vital for microorganisms [1 -3] . There is abundant ing compounds known as siderophores (Greek for ''iron bearers'') [3] . Siderophores are low-molecular-weight (õ1,000), iron in the human body, most of which is bound to hemoglobin, myoglobin, and the cytochromes. Most of the iron that is not virtually ferric-specific ligands whose function is to scavenge iron for microorganisms. Siderophore synthesis is inversely integrated to these essential proteins is bound to the iron-binding proteins (transferrin, lactoferrin, and ferritin). These ironrelated to the amount of iron in the environment and is under tight control of an operon [4] . Besides the siderophore system, withholding mechanisms make the amount of iron available to bacteria extremely small, on the order of 10 015 M. Because the microorganisms have other mechanisms for the acquisition of iron: enzymatic breakdown of iron-binding proteins [5] , reduciron requirements of microorganisms are on the order of 10 06 M, as an evolutionary response, they have developed different tion of the Fe 3/ complex to the Fe 2/ complex (leading to release of iron [6] ), and interaction of receptors present on the mechanisms to obtain it. The human host uses iron withholding as a form of nonspecific immunity to discourage infection, and microbial surface with the Fe-glycoprotein complex [7] . this sequestration is involved in the pathogenesis of anemia of inflammation (AoI). When excess iron becomes available under certain clinical circumstances (e.g., hemolysis, trauma, hemoMechanisms Developed by the Host to Deprive chromatosis, the use of desferrioxamine, iron supplementation, Microorganisms of Iron or transfusions), it becomes possible for certain microorganisms to proliferate and cause disease.
Iron withholding is mediated by a series of iron-binding proteins: ovoalbumin, transferrin, lactoferrin, and ferritin [8] . The binding and saturation characteristics of these iron-binding Iron Needs of Microorganisms proteins result in concentrations of free iron on the order of The fact that microorganisms can multiply in vivo and cause 10
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M. Moreover, under normal circumstances, there is an infections despite the virtual absence of freely available iron excess of unoccupied binding sites in plasma transferrin, which in body fluids suggests that they have the capacity to adapt are capable of binding extra iron. This extra iron-binding capacto the iron-restricted environment by the development of soity will serve to keep levels of free iron constant during periods phisticated mechanisms to overcome iron scarcity. The most of rapid entry of the metal into the circulation. important of these adaptive mechanisms is the siderophore system. Microorganisms have developed high-affinity iron-bind- [15] found that lactoferrin present in PMN AoI became a nosologic entity following the seminal article leukocytes was 14% -40% saturated with iron. Thus, lactoferrin by Cartwright and Wintrobe [26] . It is a very common type of has the capacity to bind relatively large amounts of free iron.
anemia [27] . I agree with Schilling [28] that we should abandon Lactoferrin synthesis and release from the secondary granules the misnomer ''anemia of chronic disease'' and replace it with is increased by IL-1, as part of the acute-phase reaction (APR) AoI, which better reflects our growing understanding of its [16] . Release of apolactoferrin (iron-free lactoferrin) by PMN pathogenesis. AoI is usually mild, with hematocrits ranging leukocytes into an area of bacterial growth leads to its in situ between 30% and 40% and hemoglobin levels of 9 -13 g/dL. combination with iron.
Nonetheless, in about 20% of cases, the hematocrit may drop In contrast to conalbumin and transferrin, lactoferrin's affinbelow 25% [29] . A pathological process, such as chronic infecity for iron increases as pH decreases. Thus, lactoferrin is an tions, inflammatory infections, or neoplastic diseases, is usually efficient iron scavenger and/or trap at sites of infection or present at the time of detection of AoI. The underlying problem inflammation, where the pH has been lowered by the release is usually easily identified. Occasionally, AoI is the first maniof lactic acid and other by-products of the leukocytes and/ festation of such an underlying disease. The word chronic may or microbial metabolism. Several reports have attested to the also be misleading, because changes in hemoglobin levels and importance of lactoferrin in host defenses by showing that hematocrit can occur in õ2 weeks [30] . patients with lactoferrin-deficient PMN leukocytes have an increased susceptibility to infections [17 -20] .
Two facts contribute to lactoferrin's efficiency in iron sequestration in the reticuloendothelial system. First, because of Pathogenesis of AoI its higher affinity for iron at lower than physiological pH, lactoferrin binds more iron than transferrin at sites of inflamAoI is a multifactorial and complex process [31, 32] whose many steps are mediated by cytokines such as IL-1, TNF, and mation. Second, lactoferrin receptors, while present on the surface of macrophages, are not expressed on the surface of ery-IFN. Increased plasma concentrations of these cytokines have been described in patients with disorders associated with AoI throid precursors. During the APR, the macrophages become activated. Activated macrophages exhibit an increase in the [33 -36] . In addition, the therapeutic administration of recombinant human TNF and IFN to patients has been reported to concentration of lactoferrin receptors on their surface, which further increases the internalization of iron (keeping it away produce anemia [37, 38] . AoI is mainly the result of decreased RBC production secondary to decreased iron availability and from the microorganisms and the erythroid precursors). Thus, lactoferrin-bound iron is taken up by macrophages in prefererythropoietin (EPO) dysfunction.
/ 9c3d$$oc40 09-19-97 08:26:31 cida UC: CID lization, thereby underscoring the importance of the macrophage storage capacity in the pathogenesis of AoI. Decreased iron absorption. Decreased iron absorption plays only a minor role in hypoferremia in patients with AoI. Transferrin may play a role in these changes in iron absorption. Once synthesized in the liver, apotransferrin is secreted in bile into the gastrointestinal tract lumen. In the lumen, it binds iron and delivers it to the transferrin receptor located in the brush border of the mucosal cell [45] . Because transferrin synthesis is decreased during the APR, interference with iron absorption at this step may explain the decreased iron absorption in patients with chronic inflammation.
Alterations in EPO Metabolism
There are data suggesting that EPO disturbances are a central component of the pathogenesis of AoI.
Decreased EPO synthesis. EPO release in response to ane- precursors to EPO. This unresponsiveness may be the result of macrophage-derived factors [54 -58] .
Decreased RBC survival. RBC survival in patients with

Decreased Iron Availability
AoI is typically reduced to 60 -90 days compared with the normal 90 -120 days [59, 60] . Probably more important in Decreased iron availability is due to decreased iron reutilization and decreased iron absorption.
decreased RBC life span in patients with AoI is the role of macrophages in RBC disposal. A normal function of the macroDecreased iron reutilization. In addition to the iron-binding proteins, reticuloendothelial macrophages play a central phages is removal of senescent RBCs from the circulation. Therefore, it is possible that macrophages activated by the role in decreased iron reutilization. As part of the APR, macrophages increase their lactoferrin receptors, thereby enabling inflammatory process will exaggerate this normal function. Senescent RBCs and those coated by Igs or immune complexes them to internalize more lactoferrin-bound iron. Iron released from the reticuloendothelial macrophage is reduced by inare cleared more efficiently by an activated phagocytic system [61] . Although fever per se has been reported to decrease RBC flammation [39, 40] . In patients with inflammatory conditions, ferritin synthesis is increased in the activated reticuloendothesurvival [62] , not all patients with AoI are febrile. Cartwright and Lee [63] speculated that AoI -given that lial cells [41, 42] . This increase in ferritin synthesis precedes hypoferremia [25] , thus suggesting that increased iron binding the anemia is mild and thus of little, if any, deleterious effect to the host -could represent some appropriate homeostatic by ferritin may be the mechanism responsible for the reduction in iron output from the reticuloendothelial cell.
mechanism. I submit that the purpose of AoI is to deprive invading microorganisms of iron. This possible role of AoI Iron kinetic studies have demonstrated the existence of a small labile pool of iron (compartment A in figure 1 ) with a could be integrated into the concept of ''nutritional immunity'' (figure 2). Iron withholding in patients with AoI may be conrapid turnover rate [43, 44] . The iron in this labile pool is either released into the blood or transferred to a storage pool strued as a host defense mechanism in that it is an attempt to deprive the invading microorganisms of iron as a nutrient. (compartment B figure 1) . The size and capacity for iron release of the labile pool is the same for normal individuals and for Fever (a component of the APR), independent of cytokineinduced hypoferremia, may also contribute to iron deprivation. patients with anemia secondary to rheumatoid arthritis. The storage pool, however, is greatly expanded in patients with Elevated temperature suppresses the synthesis of siderophores and their receptors [64, 65] . Thus, fever appears to have two rheumatoid arthritis. Thus, an increase in the storage pool will lead to iron withholding and play a central role in iron underutisynergistic effects aimed at decreasing bacterial growth rates:
/ 9c3d$$oc40 09-19-97 08:26:31 cida UC: CID fever, an acute and severe hemolytic disorder caused by Bartonella bacilliformis (a gram-negative bacterium found almost exclusively in Peru and Ecuador) [73] . If salmonella bacteremia occurs during the acute hemolytic phase of bartonellosis, the prognosis is worse than if it occurs following the abatement of the hemolytic process, which suggests that hemolysis (with the consequent increased iron availability) contributes to the severity of salmonella bacteremia. ''Local'' hemolysis as a result of trauma (i.e., hematoma formation) and severe burn-associated hemolysis may contribute to increased susceptibility to infections by increasing the availability of iron. Hemoglobin present in the peritoneal cavity may act as a virulence factor in patients with postoperative peritoneal infections. Experimental data support this contention [74, 75] . Certain Porphyromonas and Prevotella species can have access to iron trapped in iron-binding proteins by degrad- Figure 2 . IL-1 and other cytokines mediate both arms of nutritional immunity. By mediating fever, they decrease siderophore production ing such proteins as hemoglobin, haptoglobin, hemopexin, and by the bacteria. Through the acute-phase reaction (APR), they particitransferrin [5] .
pate in the pathogenesis of anemia of inflammation (AoI). Both these effects lead to bacterial iron deprivation.
Hemochromatosis and Other Iron Overload States
Hemochromatosis, the epitome of iron overload, is associdecreased iron availability (mediated by AoI) and decreased ated with an increased incidence of certain infections. Serum siderophore production.
from patients with hemochromatosis contains a pool of iron complex not present in healthy individuals from which bacteria can readily obtain iron [76] . Vibrio vulnificus is one of the Iron Excess and Infections microorganisms seen in association with hemochromatosis. AlDifferent mechanisms may make excess iron available for though this bacterium is usually inhibited by human serum, it microorganisms, and various specific infections appear to thrive thrives in the presence of 1 mg of hemoglobin/mL, whether or in this environment of excess iron.
not it is complexed with haptoglobin [77] . This microbe can grow rapidly in sera of individuals with hemochromatosis [78] . The growth of V. vulnificus in sera of patients with hemochroHemolysis matosis can be inhibited by the addition of human apotransferrin. Primary hemochromatosis was present in 50% of cases of Large amounts of iron can be made available during hemolysis in patients with conditions such as sickle cell crisis [66] multiple liver abscesses due to Yersinia enterocolitica, and other forms of iron overload (Bantu siderosis, thalassemia maand other hemolytic disorders [67] . Iron thus released is not only made available for microorganisms but also affects the jor, and iron therapy) were present in 13% [79] . The incidence of infections with Yersinia pseudotuberculosis in patients with mononuclear phagocytic system, one of whose roles is the clearance of bacteria from the bloodstream [68, 69] Before the use of EPO, these patients received multiple transfusions (each unit of whole blood conrichia coli become lethal when they are administered together with hemoglobin to rats but do not become lethal if sufficient tained 200 mg of iron). These patients also received frequent parenteral iron preparations. Moreover, one or more alleles haptoglobin to bind all the hemoglobin is also given to the animals.
for hemochromatosis may be present that predispose patients undergoing dialysis to iron overload [81] . Salmonella infections are seen with increased frequency in the presence of hemolytic disorders such as malaria and bartoIt is therefore of interest that 10 episodes of yersinia bacteremia (nine due to Y. enterocolitica and one due to Y. pseudotunellosis. During the era of malariotherapy for patients with neurosyphilis, the frequency of salmonella bacteremia was so berculosis) were detected in a cohort of Belgian patients undergoing dialysis [82] . Before having yersinia bacteremia, the high that considerations were given to administering a vaccine against Salmonella enteritidis infection to these patients [71] .
patients had received a mean dose of parenteral iron { SD of 24.9 { 19.5 g; their mean ferritin concentration { SD was 2.1 An association between bacteremia due to non-typhi Salmonella species and spontaneous malaria has also been reported { 2.125 ng/mL, and stained bone marrow specimens from five patients were strongly positive for iron. Two of these episodes [72] . occurred within 4 months of the initiation of desferrioxamine associated with certain bacterial infections in which free iron in the stored blood (as a result of in vitro hemolysis) may play therapy (vide infra). Data on invasive yersinia disease and iron status were obtained for 1,656 patients undergoing dialysis in a role. Increased iron availability in the stored blood facilitates the proliferation of certain microorganisms. In most cases of Belgium. Yersinia bacteremia was described in five of 539 individuals with serum ferritin levels of ú500 ng/mL, while transfusion-associated yersinia bacteremia reported in the literature, the involved blood had been stored for ú3 weeks (there no cases occurred in 882 individuals with serum ferritin levels of õ500 ng/mL (P õ .05).
is a linear correlation between duration of storage and extent of hemolysis) [98] . Besides iron availability, the temperature at which blood is stored plays a role in the specific organisms
Iron Supplementation
involved. Yersinia and other psychrophilic organisms (such as Infant botulism differs from foodborne botulism in that the Enterobacter agglomerans) grow well at 4ЊC, the temperature botulinus toxin is elaborated in vivo (i.e., in the gastrointestinal at which blood is stored. Yersinia can multiply to large numbers tract). There is microbiological evidence [83] iron to bacteria through mobilization from tissue deposits (the The classical association of mucormycosis (zygomycete) first step in the elimination of the excess iron burden and an with diabetic ketoacidosis and other disorders characterized by incidental occurrence when desferrioxamine is being used for acidosis (i.e., renal tubular acidosis) is most likely multifactoaluminum chelation). Iron is thus made available to microorrial. There is evidence that one of the pathogenetic factors is ganisms, which having the capacity through their siderophore increased iron availability secondary to acidosis [12, 13] . receptors to internalize and utilize it, can increase their growth and virulence [85, 86] .
There are many reports on the increased incidence of certain Therapeutic Implications of the Role of Iron in Infections types of infections, such as yersinia [82, 87 -89] and zygomyUnderstanding the molecular basis of iron acquisition by cete [90 -92] infections, related to the therapeutic use of desferpathogenic microorganisms has provided new insights that are rioxamine. The frequent use of desferrioxamine for treatment potentially useful for the development of innovative therapeutic of aluminum toxic effects in patients with chronic renal failure measures and alternatives to antibiotic use. One such approach potentially increases the risk of infection with iron-dependent is the production of antibacterial agents that interfere with the organisms. In the setting of renal failure, the half-lives of dessiderophore -siderophore receptor system. The siderophore enferrioxamine and its chelates (ferroxamine and aluminoxamine)
terochelin is produced by a number of pathogenic enterobacare markedly prolonged, by as much as 10-fold. This alteration teria and could be complexed with ions other than iron (such in desferrioxamine pharmacokinetics will allow microorganas scandium [Sc ]) to yield antimetabolites. isms longer periods to utilize the chelated iron. There have Experimental data suggest this may be a viable approach been multiple reports of invasive zygomycosis in patients with [100 -102] . The use of ferrisiderophore receptors as antigenic chronic renal failure who are treated with desferrioxamine sites for the development of vaccines has also been explored [93 -96] . On the basis of these reports, the use of this agent [103] . Eaton et al. [70] have proposed the use of haptoglobin for patients with renal failure should be approached with great in the treatment of potentially fatal infections in which available caution.
hemoglobin may have a role. Although the main indications for the use of desferrioxamine are iron and aluminum overload, it is likely that its therapeutic indications will extend to such conditions as malignancy and Summary autoimmune disorders [97] . Thus, the number of patients at Iron plays a role both in bacterial pathogenicity and in host risk for desferrioxamine-associated invasive yersinia infection defense mechanisms, which has frequently been underestiand mucormycosis may increase in the near future.
mated. Bacterial pathogenicity is multifactorial, and iron is but one of its components. Besides the complex role iron plays
Blood Transfusion
directly in microbial biology (as described in this review), excess iron also leads to decreased phagocytosis and deficient Repeated blood transfusions can lead to iron overload. In addition to iron overload, transfused blood per se has been oxidative metabolism. 
